Medartis Holding AG (MED.SW)

80.50 +0.30 (+0.37%) As of 09:00AM CEST. Market open.

Medartis Holding AG

Hochbergerstrasse 60E
Basel 4057
Switzerland
41 61 633 34 34
https://www.medartis.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 747

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Christoph Bronnimann	CEO & Member of Executive Management Board	1.37M	N/A	1966
Dr. Thomas Straumann	Founder & Vice Chairman	291.97k	N/A	1963
Dr. Dirk W. Kirsten	CFO & Member of the Executive Management Board	N/A	N/A	1968
Ms. Mareike Loch	VP of EMEA & Member of Executive Management Board	N/A	N/A	1970
Mr. Manuel Schaer	CTO & Member of the Executive Board	N/A	N/A	1970
Mr. Mario Della Casa	COO & Member of Management Board	N/A	N/A	1975
Ms. Inge Maes	Chief Human Resources Officer & Executive Management Board Member	N/A	N/A	N/A
Mr. Fabian Hildbrand	Head of Corporate Communications	N/A	N/A	N/A
Ms. Anisha Wharton	Head of Regulatory Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.

Description

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was founded in 1997 and is headquartered in Basel, Switzerland.

Corporate governance

Medartis Holding AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.